A Case of Indomethacin Toxicity: The Drug Information Network and Its Benefits in Therapy

The Arthritis Foundation-Primer on Rheumatic Diseases, 7th ed., 1973. Sec. 42, Gout pp. 95–103.

Boardman P. L. Hart F. D. : Side effects of indomethacin, Ann. Rheum. Dis. 26:127–132, 1967.

Calabro J. J. : Long term reappraisal of indomethacin, Drug Ther. 5:47–60, 1975.

Koda-Kimble M. A. : Applied Therapeutics for Clinical Pharmacists, 2nd ed. 1978. Chapter 22 (pp 410–427), Chapter 23 (pp 428–448). Applied Therapeutics Inc. San Francisco, 1978.

Hart F. D. : Which antirheumatic drug, Drugs 11:451–460, 1976.

Smyth Brano : Antirheumatic drugs: Clinical pharmacological and therapeutic aspects, Drugs 10:394–425, 1975.

American Hospital Formulary Service. Washington D.C., American Society of Hospital Pharmacists, 1978 (28:08).

Goodman S. Gilman A. : The Pharmacological Basis of Therapeutics, 5th ed. 1975 (pp 341–343).

Horrolin D. : Indomethacin, prostaglandins, and schizophrenia, Br. Med. J. 2:1357, 1977.

Abeles J. H. : Schizophrenia as a prostaglandin-deficiency disease, Lancet 1:1319, 1977.

Gotz V. : Paranoid psychosis with indomethacin, Br. Med. J. 1:40, 1978.

Carney M. W. P. : Paranoid psychosis with indomethacin, Br. Med. J. 3:994, 1977.

Thompson M. Percy J. S. : Further experience with indomethacin in the treatment of rheumatic disorders, Br. Med. J. 1:80, 1966.

Rothermich N. D. : An extended study of indomethacin: I. Clinical pharmacology, JAMA 195:531, 1966.

Kelsey W. M. Scharyj M. : Fatal hepatitis probably due to indomethacin, JAMA 199:586, 1967.

Fenech F. F. Bannister W. H. Grech J. L. : Hepatitis with biliverdinaemia in association with indomethacin therapy, Br. Med. J. 3:155, 1967.

Ditil J. : Analgesics-antipyretics and etiology and pathogenesis of psychosis, Activ. Nerv. Super. (Praha) 13:237, 1971.

Boyer T. D. Reynolds T. B. : The effect of indomethacin on renal blood flow and creatinine clearance in patients with cirrhosis, Gastroenterology 70:A121, 979, 1976.

Arisz L. Donker J. M. Brenstjens J. R. H. vander Hem G. K. : The effect of indomethacin on prostaglandins and kidney function in the nephrotic syndrome, Acta Med. Scand. 199:121, 1976.

Bossa G. Giordano M. : Use of indomethacin in combination with other antirheumatic drugs in the therapy of chronic inflammatory rheumatism, Clin. Ther. 62:205, 1972.

Aylward M. Parker R. J. Holly F. Maddock J. Davies D. B. : Long-term study of indomethacin and alclofenac in treatment of rheumatoid arthritis, Br. Med. J. 2:7, 1975.

Hingorani K. Biswas A. K. : Double-blind controlled trial comparing oxyphenbutazone and indomethacin in the treatment of acute low back pain, Br. J. Clin. Pract. 24:120, 1970.

Campanacci L. : Indomethacin in glomerulone-phropathies, Arzneimittel-forschung 21(11a):1851, 1971.

Williamson H. E. Bourland W. A. Marchand G. R. : Inhibition of furosemide induced increase in renal blood flow by indomethacin, Proc. Soc. Exp. Biol. Med. 148:164, 1975.

Iowa Drug Information Service, Procedure Manual, Univ. of Iowa, Iowa City, Iowa, 1970–78.

Current Contents - Clinical Practice, Institute for Scientific Information, Philadelphia, PA, 1978.

Index Medicus, National Library of Medicine, U.S. Pub. Health Serv., Dept. of H.E.W., Bethesda, MD, 1979.